At a glance Platform type / Women-focused GLP-1 telehealth + dietitian coaching Primary medication / Semaglutide (oral or injectable, dose-titrated) Regulatory basis / GLP-1 prescribing follows FDA-approved indications for BMI 30 or BMI 27 with a weight-related comorbidity Hard contraindications / Personal or family history of MTC or MEN2, pregnancy, active anorexia or bulimia Key safety signal / GLP-1 agents carry an FDA boxed warning for thyroid C-cell tumors in rodents Complaint pattern / Most documented complaints relate to cancellation difficulty and billing, not clinical harm Trial benchmark / STEP-1 (N=1,961): semaglutide 2.4 mg produced 14.9% mean body-weight loss at 68 weeks vs
RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas
Prevention through lifestyle changes is key
Dal Negro RW, Wedzicha JA, Iversen M, et al
Avoid cruciferous vegetables like broccoli and cabbage temporarily, as they ferment easily and produce additional gas in your slowed stomach
Laura Reed, DNP, has struggled with her weight her entire life, despite her familys long history as health professionals
